Kosh is a Digital Content Designer with an extensive background in Graphic Design and UX & UI design. He specializies in developing online visual content and supporting various teams across the globe. In his current role he also performs analysis on the customer's journey, to identify the best user experience and enhance engagement.
Latest from Kosh Naran
More than 100 biopharma executives and experts told Scrip their predictions for therapeutic area advances in the coming year. The recent commercial success of GLP-1s in diabetes and obesity and their potential in further disease areas fuelled excitement around the metabolic space. Expectations were also positive in neurology following the launch of Leqembi for Alzheimer’s disease in 2023, while the multiple opportunities to improve cancer treatment kept oncology top of the pile overall.
Although pharmaceuticals are exempt from the US reciprocal tariff policy, for now, the escalating global trade war is already posing practical on-the-ground problems for some companies, In Vivo investigates.
Exec summary will go here...Exec summary will go here...Exec summary will go here...Exec summary will go here...Exec summary will go here...Exec summary will go here...